Main
>
OPHTHALMOLOGY
>
Diabetic Retinopathy
>
Treatment
>
Co: CH. R. RanibizuMAb Inj.
Co: CH. R. RanibizuMAb Inj.'s subsections
(*) USA Approval Date: 2017. 04.18.
Company
TradeMark
Co: CH. R. RanibizuMAb Inj.'s products
This section has no products